Primary Health Properties PLC
(Incorporated in the United Kingdom)
Company Number: 3033634
LSE Share Code: PHP
JSE Share Code: PHP
ISIN Code: GB00BYRJ5J14
LEI: 213800Y5CJHXOATK7X11
("PHP" or the "Company")
Notice of Interim Results
Primary Health Properties PLC (LSE: PHP), one of the UK's leading investors in modern primary healthcare facilities, will announce its interim results for the six months ended 30 June 2024 on Wednesday, 24 July 2024.
A presentation for analysts will be held at Buchanan Communications on the day of results at 10.00am UK time (11.00am SAST) and will also be accessible via live video webcast and a live conference call facility. Following the presentation there will be a moderated Q&A session.
To access the briefing, please log on or dial in shortly before 10.00am UK time (11.00am SAST) via the details below:
Webcast: https://stream.brrmedia.co.uk/broadcast/6656fff0173fd460b8116b1e
Telephone: UK-wide: +44 (0) 33 0551 0200
South Africa Toll Free: 0 800 980 512
Password: Quote "PHP half year results" when prompted
If you would like to register your interest in attending the meeting, please contact Buchanan at php@buchanan.uk.com.
A recording of the webcast will be made available from c.12.00pm UK time (13.00pm SAST) on 24 July 2024 on the PHP website, https://www.phpgroup.co.uk/.
Further details:
Mark Davies Chief Executive Officer Tel: 07968 122448 | Richard Howell Chief Financial Officer Tel: 07766 072272 |
| |
David Rydell / Stephanie Whitmore / Verity Parker Buchanan Communications Tel: +44 (0) 20 7466 5066 | |
The Company has a primary listing on the London Stock Exchange and a secondary listing on the JSE Limited.
United Kingdom
5 June 2024
Sponsor: PSG Capital
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.